Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture, Bladder Urothelial Cell
DISEASE(S): Bladder Transitional Cell Papilloma
SUBMITTER: Jiawei Chen
LAB HEAD: Jiawei Chen
PROVIDER: PXD035722 | Pride | 2024-05-23
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
R20210901912_UMUC_G3IP.msf | Msf | |||
R20210901912_UMUC_G3IP.raw | Raw | |||
R20210901912_UMUC_IGG.msf | Msf | |||
R20210901912_UMUC_IGG.raw | Raw |
Items per page: 1 - 4 of 4 |
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 20231212 7
Immune checkpoint inhibitors (ICIs) show promise as second-line treatment for advanced bladder cancer (BLCA); however, their responsiveness is limited by the immune evasion mechanisms in tumor cells. This study conduct a Cox regression analysis to screen mRNA-binding proteins and reveals an association between Ras GTPase-activating protein-binding protein 1 (G3BP1) and diminished effectiveness of ICI therapy in patients with advanced BLCA. Subsequent investigation demonstrates that G3BP1 enhance ...[more]